Dergiler / Turkish Journal of Urology / 2021 / Cilt: 47 - Sayı: 1

Genetic polymorphisms in CLDN14 (rs219780) and ALP (rs1256328) genes are associated with risk of nephrolithiasis in Egyptian children

Sayfa
73–80
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: CLDN14 rs219780 and ALPL rs1256328 SNPs might raise the risk of nephrolithiasis in Egyptian children, and might be used as genetic markers in these patienst.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Nephrolithiasis results from metabolic and anatomic abnormalities together with genetic factors.
📊
Temel Bulgular & Veri:Claudin 14 (CLDN14) is a protein that regulates the passage of small solutes through the kidneys.
💡
Sonuç & Katkı:Conclusion: CLDN14 rs219780 and ALPL rs1256328 SNPs might raise the risk of nephrolithiasis in Egyptian children, and might be used as genetic markers in these patienst.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Nephrolithiasis results from metabolic and anatomic abnormalities together with genetic factors. Claudin 14 (CLDN14) is a protein that regulates the passage of small solutes through the kidneys. Alkaline phosphatase (ALPL) hydrolyzes the pyrophosphate to free phosphate, proposing its enabling role in nephrolithiasis development. Solute carrier family 13 member 2 (SLC13A2) encodes Na+-Pi cotransporter 2a, which is responsible for the renal absorption of phosphate. We aimed to detect the association between CLDN14, ALPL, and SLC13A2 genetic variants and susceptibility to nephrolithiasis in the Egyptian pediatric population. Material and methods: We enrolled 204 consecutive pediatric patients with nephrolithiasis, and 126 normal individuals served as controls. Real-time polymerase chain reaction analysis of CLDN14 rs219780, ALPL rs1256328, and SLC34A1 rs11746443 single-nucleotide polymorphisms (SNPs) was performed. Results: We found that individuals carrying the T allele of CLDN14 rs219780 and ALPL rs1256328 SNPs had a significantly higher risk of nephrolithiasis than the controls (p=0.001 and 0.001, respectively). Genetic association analyses identified that CLDN14 rs219780 and ALPL rs1256328SNPs were significantly associated with the nephrolithiasis status (odds ratio [OR] =4.51; 95% confidence interval [CI]=2.758– 7.374; p=0.001 and OR=6.088; 95% CI=3.651–10.152; p=0.001, respectively). The sequence variant ALPL rs1256328 T allele had a significant correlation with the increased serum alkaline phosphatase levels in children with nephrolithiasis (p=0.02). No significant association was found between SLC34A1 rs11746443 SNP and the risk of nephrolithiasis (p=0.5). Conclusion: CLDN14 rs219780 and ALPL rs1256328 SNPs might raise the risk of nephrolithiasis in Egyptian children, and might be used as genetic markers in these patienst.

🔖

Bu Makaleye Atıf Yap

ELSHAMAA, M. F., FADEL, F. I., KAMEL, S., FAROUK, H., AHMADY, M., RAMADAN, Y. (2021). Genetic polymorphisms in CLDN14 (rs219780) and ALP (rs1256328) genes are associated with risk of nephrolithiasis in Egyptian children. Turkish Journal of Urology, Cilt: 47 - Sayı: 1, 73–80. https://ajindex.com/articles/413254

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol 2017
  2. [Crossref] 2. Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, et al. Medical management of kidney stones: AUA guideline. J Urol 2014
  3. [Crossref] 3. Türk C, Petrík A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 2016
  4. [Crossref] 4. Mosharafa AA. Prevalence of renal cysts in a Middle-Eastern population: an evaluation of characteristics and risk factors. BJU Int 2008
  5. [Crossref] 5. Scales Jr. CD, Smith AC, Hanley JM, Saigal C.S. Prevalence of kidney stones in the United States. Eur Urol 2012
  6. [Crossref] 6. Moochhala SH, Sayer JA, Carr G, Simmons NL. Renal calcium stones: insights from the control of bone mineralization. Exp Physiol 2008
  7. [Crossref] 7. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005
  8. [Crossref] 8. Monico CG, Milliner DS. Genetic determinants of urolithiasis. Nat Rev Nephrol 2011
  9. [Crossref] 9. Khan SR, Pearle MS, Robertson WG, Gambaro G5, Canales BK, Doizi S, et al. Kidney stones. Nat Rev Dis Prim 2016
  10. 16008. [Crossref] 10. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol 1997
  11. Goldfarb DS, Fischer ME, Keich Y, Goldberg J. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 2005
  12. [Crossref] 12. Yasui T, Okada A, Hamamoto S, Ando R, Taguchi K, Tozawa K, et al. Pathophysiology-based treatment of urolithiasis. Int J Urol 2017
  13. [Crossref] 13. Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, Gudbjartsson DF, et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 2009
  14. [Crossref] 14. Guha M, Bankura B, Ghosh S, Pattanayak AK, Ghosh S, Pal DK, et al. Polymorphisms inCaSRandCLDN14 genes associated with increased risk of kidney stone disease in patients from the eastern part of India. PLoS One 2015
  15. [Crossref] 15. Oddsson A, Sulem P, Helgason H, Edvardsson VO, Thorleifsson G, Sveinbjörnsson G, et al. Common and rare variants associated with kidney stones and biochemical traits. Nat Commun 2015
  16. [Crossref] 16. Yasui T, Okada A, Urabe Y, Usami M,